C9orf72 and fragile X-associated tremor/ataxia syndrome: Consequently, these inhibitors hold promise as a novel treatment for both C9orf72 ALS/FTD and FXTAS, both of which are caused by RAN translation of aberrantly amplified microsatellites [58].